S 2617 · in committee · significant
Reducing Drug Prices for Seniors Act.
- healthcare
What this bill does
- Medicare drug plans must calculate senior copayments based on the actual negotiated price of drugs, not the full list price.
- Medicare beneficiaries and prescription drug plan insurers are affected by this pricing change.
- The change takes effect when implemented by CMS and reduces out-of-pocket costs for seniors when manufacturers offer price concessions.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How would tying senior copayments to negotiated prices rather than list prices affect drug manufacturers' willingness to offer discounts?
- 02
What evidence exists that current list-price-based copayments prevent seniors from accessing medications they need?
- 03
Which stakeholders—seniors, insurers, manufacturers, or taxpayers—would bear the financial impact if this pricing mechanism reduces overall drug revenue?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.
Sponsor · D-NV
Jacky Rosen
Citizen cosponsors
0
In Congress
1/ 100
Senators cosponsoring
Introduced 2025-07-31
Joining the bill
Legislative timeline
2025-07-31 · senate · IntroReferral
Read twice and referred to the Committee on Finance.
2025-07-31 · IntroReferral
Introduced in Senate
Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.